Hemoglobina glicosilada como factor pronóstico en pacientes diabéticos con sepsis en el Hospital General Guasmo Sur en el periodo 2019 a mayo del 2021.

Abstract

Glycosylated hemoglobin is a biomarker that indicates the patient's glycemic status in the last 3 months. Due to different studies found, its relationship with the presence of complications, long hospital stay, mortality and among others has been of great importance in order to implement it as a prognostic factor in septic patients. General objective: To determine the relationship of glycosylated hemoglobin as a prognostic factor in diabetic patients with sepsis treated at the Guasmo Sur General Hospital from 2019 to May 2021. Methodology: A retrospective, cross-sectional, observational, analytical study was carried out in which septic diabetic patients with glycosylated hemoglobin test at admission or during their stay at the Guasmo Sur General Hospital in the period from 2019 to May 2021. Results: The population sample was 116 patients with glycosylated hemoglobin test taken at admission or during your stay. The biological sex to predominate was male and the most frequent age group was 57 to 66 years. The most recurrent glycosylated hemoglobin value range was from 6.5% to 8.5%, representing 64.8% of the cases, with SOFA from 5 to 15 points and APACHE II from 5 to 37 points. In addition, 92% of the patients required mechanical ventilation and 38.7% had complications: 26.6% with cerebrovascular events, 17.7% with pneumothorax, and 22.4% mortality. Conclusions: According to the results obtained, it is concluded that patients with higher levels of glycosylated hemoglobin have greater severity upon admission to Intensive Care.